Over recent years, researchers have become increasingly interested in the link between the immune system and Parkinson's disease. Using a mouse model, scientists recently explored the potential role of a bacterial gut infection.
Parkinson's disease develops due to the slow depletion of dopamine-producing neurons in a part of the brain called the substantia nigra.
This region of the brain plays an important role in movement, so symptoms include shaking, tremor, and rigidity.
The primary risk factor for Parkinson's is age and, as the population of the United States is slowly aging, the number of cases is steadily growing.
Some believe that we are approaching a Parkinson's pandemic; globally, between 1990–2015, the number of Parkinson's cases has doubled to more than 6 million.
Some predict the number to double again to 12 million by 2040.
Although researchers have studied the disease for decades, they still have many questions about how and why brain cells are destroyed.
Parkinson's and the immune system
Autoimmune diseases are conditions where an individual's immune system confuses the body's cells for pathogens and destroys them.
A recent study, published in
Around 10 percent of Parkinson's cases are due to mutations in genes that code for the proteins PINK1 and Parkin, which play a role in
Individuals who carry these mutations are more likely to develop Parkinson's at an
However, when scientists knock these genes out of mice, the mice do not develop Parkinson's disease or any similar symptoms. Why these knock-out mice are immune to Parkinson's has foxed researchers.
According to the authors, it means that "factors other than the loss of function of these proteins are likely to be required to trigger Parkinson's." They set out to identify these other factors.
Joining the dots
The authors wanted to find further evidence that there is a link between PINK1 and Parkin proteins, mitochondria, the immune system, and Parkinson's.
They believe that knock-out mice do not develop Parkinson's because of how the researchers have reared them. The mice used in these studies are typically germ-free, meaning that they have never encountered bacteria.
So, to test this hypothesis, they infected young mice that lacked PINK1 and Parkin with Escherichia coli. This caused mild intestinal symptoms in the mice.
As expected, the early-life infection triggered the occurrence of Parkinson's-like motor symptoms as they got older. The scientists also identified a loss of dopaminergic neurons in their brains.
When the scientists gave the mice L-DOPA — a drug used to treat the symptoms of Parkinson's — their symptoms improved, inferring that the condition has similarities to the human condition.
In mice with normal versions of PINK1 and Parkin, the immune system deals with pathogens appropriately. However, the authors believe that in animals without the Parkinson's-related genes, the gut infection triggers an abnormal immune response that overruns and attacks healthy cells.
A complex tale
The new findings build on
In the previous study, they showed that PINK1 and Parkin suppress a mitochondria-based pathway that promotes an immune response to inflammation. They infer that in individuals without functioning copies of PINK1 and Parkin, the immune response might be allowed to spill over and continue unabated.
In their latest study, the scientists identified T lymphocytes that responded to host tissues in the brains of the mice. When they tested these cells in a culture dish, the cells attacked healthy neurons. The authors state that:
"These data [...] provide a pathophysiological model in which intestinal infection acts as a triggering event in Parkinson's disease, which highlights the relevance of the gut–brain axis in the disease."
In the classic model of Parkinson's disease, dopaminergic neurons die because toxic proteins build up inside the cells. This study, however, suggests that an overzealous immune response that might have been sparked years earlier destroys the cells.
This study does not conclude that all cases of Parkinson's disease are autoimmune, but the results do imply that there is a role for the immune system.
Of course, this work was carried out in a mouse model, so there is no guarantee that the findings will relate to humans. Also, not all people with Parkinson's disease have mutations in the genes that code for PINK1 and Parkin, so it is not clear whether similar mechanisms are involved in all cases.
It will be some time before Parkinson's gives up all of its secrets, but it seems that the story will involve an interplay between the immune system, genetics, mitochondria, and the brain.